Drug intelligence / Profile preview

4-(2,2,2-trifluoroethyl)-L-phenylalanine

Development stage: Unknown
Modality: Small Molecules

Overview

4-(2,2,2-trifluoroethyl)-L-phenylalanine is a synthetic derivative of the amino acid L-phenylalanine in which a trifluoroethyl group is substituted at the para position of the phenyl ring. It belongs to the class of organic compounds known as phenylalanine and derivatives. This compound has been studied primarily as an experimental molecule and does not have any approved medical indications or established mechanism of action in humans. There are no reported clinical trials or therapeutic uses for this compound as of now[1][2]. Its primary use appears to be in research settings.

Other names: 4-(2,2,2-trifluoroethyl)-L-phenylalanine

Targets

CaSR (Extracellular calcium-sensing receptor)

Beyond the preview

Go deeper on 4-(2,2,2-trifluoroethyl)-L-phenylalanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-(2,2,2-trifluoroethyl)-L-phenylalanine.

Explore the full profile